Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1143220200630020150
Obstetrics & Gynecology Science
2020 Volume.63 No. 2 p.150 ~ p.157
Robotic-assisted interval cytoreductive surgery in ovarian cancer: a feasibility study
Carbajal-Mamani Semiramis L.

Schweer David
Markham Merry J.
Esnakula Ashwini K.
Grajo Joseph R.
Castagno Jacqueline C.
Cardenas-Goicoechea Joel
Abstract
Objective: The primary objective was to assess the feasibility of robotic-assisted interval cytoreductive surgery for achieving complete cytoreduction for patients with advanced-stage ovarian cancer. The secondary objective was to examine the perioperative outcomes.

Methods: A retrospective study of 12 patients with stage IIIC or IV ovarian, fallopian tube, and primary peritoneal carcinoma who underwent interval cytoreductive surgery after neo-adjuvant chemotherapy.

Results: Optimal cytoreduction was achieved in 100% of selected patients. Complete cytoreductive surgery was achieved in 75% of patients. The estimated mean blood loss was 100 mL. The median length of hospital stay was 2 days. Perioperative complication and 30-day readmission rates were 8.3% (1 patient). The median follow-up time was 9.5 months.

Conclusion: Robotic-assisted interval cytoreductive surgery in ovarian cancer is safe and feasible and may be an alternative to standard laparotomy in selected patients.
KEYWORD
Robotic surgical procedure, Ovarian cancer, Cytoreductive surgical procedure
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø